arrow
L

Lidwine W. Tick

Maastricht University
H指数:30
被引数:3,773

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes

65岁及以上新诊断急性髓系白血病患者的去甲基化药物联合维奈克拉治疗——一项关于药物使用和治疗结果的全国性研究

2026-08-010
PRE
Flow Cytometry-Based Measurable Residual Disease Assessment in Patients With Acute Myeloid Leukemia Receiving Non-Intensive Chemotherapy

基于流式细胞术的可测量残留病灶评估在接收非强化化疗的急性髓系白血病患者中的应用

2026-03-190
PREAI
Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/refractory acute myeloid leukemia
2026-03-011
PRE
Associations of various medical nutrition therapy strategies with body

各种医学营养治疗策略与身体之间的关联

2025-06-010
PRE
Midostaurin added to 10-day decitabine, for patients unfit for intensive chemotherapy with AML and higher risk MDS, irrespective of FLT3 mutational status, does not improve outcome
2024-10-050
OAAI
Impact of comorbidity on health-related quality of life in newly diagnosed patients with lymphoma or multiple myeloma: results from the PROFILES-registry
2024-09-160
PRE
Changes in nutritional status and associations with physical and clinical outcomes in acute myeloid leukemia patients during intensive chemotherapy
2024-08-100
PRE
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial
2023-12-015
OAAI
Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial
2023-09-016
OAAI
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine
2023-06-193
OAAI
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome
LEUKEMIA
IF13.4
2022-07-229
OA
Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study)

体育锻炼对乳腺癌患者化疗后认知功能的影响: 一项随机对照试验 (PAM研究)

2022-05-2646
OAAI
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial
2022-03-0119
OAAI
Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial
2022-02-119
OAAI
Web-Based Return of Individual Patient-Reported Outcome Results Among Patients With Lymphoma: Randomized Controlled Trial
2021-12-1410
OAAI
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial

来那度胺在新诊断的年轻和中年AML患者的强化治疗中的补充: HOVON-SAKK-132试验

2021-02-2241
OA